ArticleMycorrhiza2025
Arbuscular mycorrhizal fungi enhance the quality of Polygala tenuifolia through metabolomic reprogramming.
Article in Mycorrhiza, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Arbuscular mycorrhizal fungi mitigate cadmium toxicity in plants: A global meta-analysis.Mycorrhiza · 2025Pooled it
- Physiology, Metabolomics, and Transcriptomics Reveal Effects of AMF andMetabolites · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Arbuscular mycorrhizal fungi (AMF) establish symbiotic associations with most plants and play a crucial role in enhancing the quality of medicinal plants. Although AMF is widely applied to improve growth and pharmacological properties, their regulatory mechanisms in Polygala tenuifolia remain unclear. In this study, we systematically examined the effects of five AMF species on the growth and metabolism of P. tenuifolia through pot experiments, integrating phenotypic traits, physiological indices, and untargeted metabolomics. Among the tested fungi, Funneliformis mosseae significantly promoted plant growth and induced the highest accumulation of 3',6-disinapoylsucrose (DISS), a key bioactive metabolite. Metabolomic profiling revealed that AMF, particularly F. mosseae, reprogrammed root metabolism by modulating biosynthetic pathways related to unsaturated fatty acids, diterpenoids, and flavonoids. Correlation analysis revealed that DISS levels were strongly associated with AMF-induced growth promotion index (GPI), total chlorophyll, and flavonoid content, and closely linked to shifts in key metabolites within these pathways. These findings suggest that AMF enhance P. tenuifolia growth and medicinal quality through metabolic reprogramming. This study provides a theoretical basis for selecting efficient AMF species for precision cultivation of medicinal plants and lays the groundwork for future exploration of gene-level mechanisms driving quality formation in P. tenuifolia.
Indexed as
Identifiers
41222742What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.